logo-loader
AIM:GDR

Genedrive PLC

Receive alerts
Market:
AIM
Market Cap:
£38.88 m
Price
74.78 GBX
Change
-9.90%
52 weeks high
302.60
52 weeks low
6.25

In brief

Genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. We are passionate about the opportunity to not only build a sustainable business around molecular diagnostics, but to play an important role in the diagnostic and treatment challenges presented by Global Health issues.

Deep dive We explore the investor case for growth companies

Snapshot

  • Developed and easy-to-use diagnostic device
  • Rocketed during crisis with coronavirus tests
  • Hepatitis C and neonatal deafness tests also in development